Impax Laboratories Announces Voting Results from 2011 Annual Meeting of Stockholders
May 11 2011 - 9:00AM
Business Wire
Impax Laboratories, Inc. (NASDAQ: IPXL) held its
2011 Annual Meeting of Stockholders yesterday in San Mateo,
California. Impax stockholders elected to a one-year term each
of the seven nominees for director named in the Company’s proxy
statement, approved, on an advisory basis, the compensation of the
Company’s executive officers as described in the annual meeting
proxy statement (“say-on-pay” vote) and recommended that future
advisory votes on “say-on-pay” occur every year.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. is a technology based specialty
pharmaceutical company applying its formulation expertise and drug
delivery technology to the development of controlled-release and
specialty generics in addition to the development of branded
products. Impax markets its generic products through its Global
Pharmaceuticals division and markets its branded products through
the Impax Pharmaceuticals division. Additionally, where
strategically appropriate, Impax has developed marketing
partnerships to fully leverage its technology platform. Impax
Laboratories is headquartered in Hayward, California, and has a
full range of capabilities in its Hayward, Philadelphia and Taiwan
facilities. For more information, please visit the Company's Web
site at: www.impaxlabs.com.
Impax Laboratories, Inc. (delisted) (NASDAQ:IPXL)
Historical Stock Chart
From May 2024 to Jun 2024
Impax Laboratories, Inc. (delisted) (NASDAQ:IPXL)
Historical Stock Chart
From Jun 2023 to Jun 2024